Riskpilot← Back to searchSign inGet full accessNBIM NERVA AS
ASActiveOrg 932539330Bankplassen 2, 0151 OsloGeneral public administration activities · NACE 8411Est. 20230 employees
Revenue 2024
NOK 0
EBITDA margin
—
-372% vs 2023
Equity ratio
39.1%
Financial strength
Net profit 2024
NOK 51,9M
+163% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -140K | -372% |
| Net profit | NOK 51,9M | +163% |
| Total assets | NOK 1,5B | +11% |
| Equity | NOK 579,6M | +10% |
| Employees | 0 | — |
Legal name
NBIM NERVA AS
Org number
932539330
Legal form
Aksjeselskap
NACE code
8411 · General public administration activities
Founded
29. november 2023
Share capital
NOK 710 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Investering i og eierskap til selskaper/eierstrukturer som etableres i eller erverves i norge eller kontinentaleuropa i forbindelse med eiendomsinvesteringene til statens pensjonsfond utland som forvaltes av norges bank investment management i henhold til finansdepartements forvaltningsmandat og alt som står i forbindelse med dette, inkludert ytelse/opptak av interne lån, salg eller restrukturering knyttet til eiendomsinvesteringene.
Address
Bankplassen 2, 0151 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | −0 | −0 |
| EBITDA | −30 | −140 |
| Depreciation & amort. | −0 | −0 |
| EBIT | −30 | −140 |
| Net financials | −82 288 | 52 081 |
| Profit before tax | −82 318 | 51 941 |
| Tax | −0 | −0 |
| Net profit | −82 318 | 51 941 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 1 336 977 | 1 480 965 |
| Equity | 527 691 | 579 632 |
| Long-term debt | 806 778 | 893 564 |
| Short-term debt | 2 509 | 7 769 |
| Total debt | 809 287 | 901 333 |
EBITDA margin
-13951100.0%
This company
15.8%
Market median
-88298201% vs market
20232024
Equity ratio
39.1%
This company
38.2%
Market median
+2% vs market
20232024
Return on equity
9.0%
This company
18.4%
Market median
-51% vs market
20232024
Net profit margin
5194103400.0%
This company
8.1%
Market median
+64124733233% vs market
20232024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232024
Debt / equity
1.56×
This company
0.62×
Market median
-152% vs market
20232024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Chairman | 2025 – 2025 | |
| Board of Directors | 2023 – 2025 | |
| Chairman | 2023 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Norges Bank
NBIM NERVA AS Board members of NBIM NERVA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Oswald Dahl | Chairman | 0 companies |
| Morten Kampli | Chairman | 0 companies |
| Charlotte Wium | Board of Directors | 0 companies |
| Per Sverdrup Løken | Chairman | 0 companies |
| Camilla Mickelson Lous | Board of Directors | 0 companies |
| Olaug Synnøve Lerstøl | Board of Directors | 0 companies |